MAPK13 CLIA Kit

Produktnummer ABIN6200977

Human MAPK13 ELISA-Kit Chemiluminescent-Assay zur Quantifizierung von Human MAPK13.

Kurzübersicht für MAPK13 CLIA Kit (ABIN6200977)

Target: MAPK13 (Mitogen-Activated Protein Kinase 13 (MAPK13))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.156 ng/mL - 10 ng/mL

Applikation: ELISA

Proben: Tissue Homogenate

Produktdetails MAPK13 CLIA Kit

Untere Nachweisgrenze: 0.156 ng/mL

Verwendungszweck: Human Mitogen Activated Protein Kinase 13 (MAPK13) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates and other biological fluids.

Analytische Methode: Quantitative

Sensitivität: < 0.061 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: MAPK13 (Mitogen-Activated Protein Kinase 13 (MAPK13))

Andere Bezeichnung: Mitogen Activated Protein Kinase 13 (MAPK13)

Pathways: MAPK Signalweg, Neurotrophin Signalübertragung, Hepatitis C, BCR Signaling, S100 Proteine